Is Genomic Medicine Clinically Useful Yet?

Brian Klepper

Posted 7/16/12 on Medscape Connect’s Care and Cost

The news of my wife Elaine’s primary peritoneal cancer 27 months ago began a fevered effort to learn all we could about her disease and our options. Peritoneal cancer, which is close in form and behavior to ovarian, is rooted in the abdominal lining. “Gold standard” treatments notwithstanding, the prognosis isn’t good. After a 12-36 month remission in which tumors are inactive, the disease generally returns, and a high percentage of women are gone within 5 years of diagnosis.

Cancer elicits a primal fear that can provoke fantasy and baseless speculation. Cancer patients in remission have told us they are cured. Others, well-meaning, have announced they know someone with “exactly what you have,” and that theirs went away by applying a strict dietary or spiritual discipline.

Continue reading “Is Genomic Medicine Clinically Useful Yet?”

Cancer Survivor on N-of-One’s Direct-to-Patient Ombudsman Model

Kevin Davies

Posted 5/31/12 on Bio-IT World

The long-term success of N-of-One, a Waltham Mass.-based company offering personalized cancer information, will undoubtedly be shaped by the vision of its newly appointed CEO, Christine Cournoyer, and strategic partnerships with companies like Foundation Medicine, announced this week.

But ultimately it comes down to whether the company’s original direct-to-patient strategy works for cancer patients like Elaine Waples.

Continue reading “Cancer Survivor on N-of-One’s Direct-to-Patient Ombudsman Model”

Seeking What’s Possible

A little more than 13 months ago, my wonderful wife Elaine was diagnosed with stage 3c primary peritoneal (ovarian) cancer. So the last year has been filled with the ravages of chemo-therapy and all the miseries that attend it.

A devastating diagnosis like this forces you to reassess everything. What we found was that attitude and perspective really do matter, and are the bedrock of happiness, in good times or bad.

Continue reading “Seeking What’s Possible”